Stephan Urban
Ruprecht-Karls-Universität Heidelberg
H-index: 61
Europe-Germany
Top articles of Stephan Urban
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies | Journal of Hepatology | Lena Allweiss Annika Volmari Vithika Suri Jeffrey J Wallin John F Flaherty | 2024/2/8 |
Structure of hepatitis B/D antiviral drug Bulevirtide bound to its receptor protein NTCP | bioRxiv | Hongtao Liu Dariusz Zakrzewicz Kamil Nosol Rossitza N Irobalieva Somnath Mukherjee | 2024 |
Molecular determinants within the C-termini of L-HDAg that regulate hepatitis D virus replication and assembly | JHEP Reports | Hongbo Guo Qiudi Li Chunyang Li Yao Hou Yibo Ding | 2024/1/1 |
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells | Frontiers in Immunology | Sophia Schreiber Lisa S Dressler Eva Loffredo-Verde Theresa Asen Stephanie Färber | 2024/4/22 |
Lipopeptides for use in treating liver diseases and cardiovascular diseases | 2020/12/10 | ||
Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP | Nature Communications | Hongtao Liu Dariusz Zakrzewicz Kamil Nosol Rossitza N Irobalieva Somnath Mukherjee | 2024/3/20 |
Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022 | Pietro Lampertico Elisabetta Degasperi Lisa Sandmann Heiner Wedemeyer Cihan Yurdaydin | 2023/6/28 | |
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV | JHEP Reports | Roberto Mateo Simin Xu Alex Shornikov Tahmineh Yazdi Yang Liu | 2023/11/1 |
Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication | Journal of Hepatology | Nadine Gillich Zhenfeng Zhang Marco Binder Stephan Urban Ralf Bartenschlager | 2023/1/1 |
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections | Gut | Rani Burm Panagiota Maravelia Gustaf Ahlen Sandra Ciesek Noelia Caro Perez | 2023/6/1 |
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice | Journal of Hepatology | Florian A Lempp Tassilo Volz Elisabetta Cameroni Fabio Benigni Jiayi Zhou | 2023/11/1 |
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a … | The Lancet Infectious Diseases | Heiner Wedemeyer Katrin Schöneweis Pavel Bogomolov Antje Blank Natalia Voronkova | 2023/1/1 |
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure | Gut | Lena Allweiss Barbara Testoni Mei Yu Julie Lucifora Chunkyu Ko | 2023/5/1 |
Hepatitis delta: Epidemiology to recent advances in therapeutic agents | Nehna Abdul Majeed Benno Zehnder Christopher Koh Theo Heller Stephan Urban | 2023/10/1 | |
RBM39 shapes innate immunity through transcriptional and splicing control of IRF3 and other key factors | bioRxiv | Teng-Feng Li Arthur Lang Paul Rothhaar Oliver Gruenvogel Ombretta Colasanti | 2023 |
An RNA-based system to study hepatitis B virus replication and evaluate antivirals | Science Advances | Yingpu Yu William M Schneider Maximilian A Kass Eleftherios Michailidis Ashley Acevedo | 2023/4/12 |
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta | Journal of Hepatology | Julius Hollnberger Yang Liu Simin Xu Silvia Chang Ross Martin | 2023/9/1 |
Method and means for the rapid detection of HDV infections | 2023/12/12 | ||
Human pluripotent stem cell-derived hepatocyte-like cells for hepatitis D virus studies | Hepatology | Giovanni G Giobbe Federica Michielin Alessandro Zam-bon Stefano Giulitti Camilla Luni | 2014/10/1 |
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers | Frontiers in Pharmacology | Vanessa Zhu Jürgen Burhenne Johanna Weiss Mathias Haag Ute Hofmann | 2023/4/6 |
Co-Authors
